Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Builds Diversified Pipeline Across Neurological and Wellness Markets
June 3, 2026 — Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising.
InvestorBrandNetwork (IBN)
The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)MissionIRNewsBreaks – Perpetuals.com Ltd. (NASDAQ: PDC) Reports Strong Early UpsideOnly Adoption, Signs Datavault AI Asset Tokenization Agreement
June 2, 2026 — Perpetuals. com (NASDAQ: PDC) reported strong early adoption of its UpsideOnly trading and market prediction platform, attracting more than 30,000 active users from 185 countries and generating $4.
TrillionDollarBreaks – AI Chip Rally Fuels Fresh Questions About Sustainability of Semiconductor Boom
June 2, 2026 — Taiwan Semiconductor Manufacturing Company Ltd. (NYSE: TSM) and other semiconductor leaders are benefiting from a powerful AI-driven surge that has sent memory-chip makers such as Micron, Samsung Electronics and SK Hynix to record valuations, fueled by soaring demand for high-bandwidth memory used in data centers supporting artificial intelligence applications.
TrillionDollarBreaks – AI-Powered Wearables Transform Patient Monitoring and Clinical Decision-Making
June 2, 2026 — Apple Inc. (NASDAQ: AAPL) and other wearable-device developers are positioned to benefit as advances in artificial intelligence and edge computing turn health care wearables into powerful clinical tools capable of delivering real-time, actionable insights rather than overwhelming streams of raw data.
InvestorNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) to Report Fiscal 2026 Third Quarter Results on June 9
June 2, 2026 — Uranium Energy (NYSE American: UEC) announced that it will release its fiscal 2026 third quarter operating and financial results before the market opens on June 9, 2026. The company will host a conference call and webcast at 11:00 a.
InvestorNewsBreaks – Suntex Enterprises Inc. (OTC: SNTX) Closes Acquisition of 100-Acre South Texas Development Property
June 2, 2026 — Suntex Enterprises (OTC: SNTX) announced the closing of its previously disclosed acquisition of approximately 100 acres in South Texas through its wholly owned subsidiary, Red Spur Land & Ranch Co. Acquired for approximately $2.
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Advanced Cancer Drug Delivery Technologies
June 2, 2026 — Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a BioMedWire editorial examining how biotechnology companies are increasingly focusing on advanced drug delivery technologies to enhance the effectiveness of existing cancer therapies. The article highlights growing industry interest in nanoparticle delivery systems, intravenous reformulations and precision pharmacokinetic approaches designed to improve bioavailability, systemic exposure, tolerability and dosing consistency.
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Engages Stocks.news for Investor Relations Services
June 2, 2026 — This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.
RockBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Reports Encouraging Preliminary Results From Murdock Mountain Drill Hole
June 2, 2026 — This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.
Boots on the Ground: How SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Is Embedding Itself in the World’s Most Active Drone War
June 2, 2026 — Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.
BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Advanced Cancer Drug Delivery Technologies
June 2, 2026 — Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a BioMedWire editorial examining how biotechnology companies are increasingly focusing on advanced drug delivery technologies to enhance the effectiveness of existing cancer therapies. The article highlights growing industry interest in nanoparticle delivery systems, intravenous reformulations and precision pharmacokinetic approaches designed to improve bioavailability, systemic exposure, tolerability and dosing consistency.
MissionIRNewsBreaks – Olenox Industries (NASDAQ: OLOX) Reports 18.6 Bitcoin Mined in First Monthly Update Following CS Digital Acquisition
June 2, 2026 — Olenox Industries (NASDAQ: OLOX) reported its first monthly operating update following the acquisition of CS Digital Ventures, announcing production of approximately 18. 6 bitcoin during May 2026 and an average operational hashrate of approximately 1.
AINewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Receives U.S. Army Order for AI-Powered Threat Analysis Kit Featuring Red Cat Black Widow Drones
June 2, 2026 — Safe Pro Group (NASDAQ: SPAI), a developer of AI-enabled defense, security and situational awareness solutions, announced it has received a U. S.
BioMedNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Reports Phase 2 HARMONIC Trial Data Supporting LP-300 in EGFR-Mutant Lung Cancer
June 2, 2026 — Lantern Pharma (NASDAQ: LTRN), an AI-driven precision oncology company, reported updated Phase 2 HARMONIC trial data showing that LP-300, in combination with carboplatin and pemetrexed, demonstrated a progression-free survival benefit that increased with treatment duration in patients with EGFR Exon 21 L858R-mutant non-small cell lung cancer who had progressed following TKI therapy. The emerging data showed a median progression-free survival of 8.
AINewsBreaks – BOXABL Featured in AINewsWire Editorial on Affordable Housing and Factory-Built Home Innovation
June 2, 2026 — BOXABL announced its inclusion in an AINewsWire editorial examining how the U. S.
New Inhalable Agent Could Improve Treatment Outcomes in Lung Cancer
June 2, 2026 — A new viral-based vector that can be inhaled into the lungs could boost the anti-cancer response of the body in patients diagnosed with advanced lung cancer. This new treatment could also restore sensitivity to immune checkpoint inhibitors among patients that had become unresponsive.
Rallying Chip Stocks Reignite AI Bubble Debate
June 2, 2026 — Companies making AI chips have registered a major rally in the prices of their shares, and this has added momentum to the growing debates about whether or not these surges are fueling an AI bubble that could burst anytime. How long will this demand continue?
Stellantis Wants to Unveil 29 EV Models by 2030
June 2, 2026 — Multinational vehicle manufacturer Stellantis has revealed plans to release 29 electric vehicle models by the end of the decade. The company behind some of the world’s largest automakers will go all in on electric vehicle development over the next 5 years to launch over two dozen EV models as part of a strategic plan designed to give Stellantis an edge in the growing electric vehicle industry.
Renewable Energy Could Ease Food Production
June 2, 2026 — The disruption of global oil supplies following the Strait of Hormuz closure has pushed energy costs higher across every sector, including food. Modern food systems consume up to 30% of global oil supplies, making the fossil fuel integral to the agricultural sector.
Industrial Demand is Reshaping the Silver Market
June 2, 2026 — Silver has traditionally been viewed alongside gold as a safe-haven asset, attracting investors during inflationary periods and economic uncertainty. Today, however, the market is increasingly being driven by industrial consumption rather than investment demand alone.